Potential Improvement in the Shelf Life of Parenterals Using the Prodrug Approach: Bacampicillin and Talampicillin Hydrolysis Kinetics and Utilization Time
- 1 January 1988
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 05 (5) , 288-296
- https://doi.org/10.1023/a:1015974603901
Abstract
The utilization time for a parenteral prodrug solution with a bioavailable fraction of unity was defined as the time during which the totalof the prodrug concentration and the drug concentration...Keywords
This publication has 12 references indexed in Scilit:
- Carbenicillin Prodrugs: Stability Kinetics of α-phenyl and α-indanyl Esters in Aqueous SolutionJournal of Pharmaceutical Sciences, 1979
- Pharmacokinetic Comparison of Oral Bacampicillin and Parenteral AmpicillinAntimicrobial Agents and Chemotherapy, 1978
- Pharmacokinetics of Bacampicillin Compared with Those of Ampicillin, Pivampicillin, and AmoxycillinAntimicrobial Agents and Chemotherapy, 1978
- Gastrointestinal absorption and metabolism of two35S-labelled ampicillin estersEuropean Journal of Clinical Pharmacology, 1976
- Bacampicillin: a New Orally Well-Absorbed Derivative of AmpicillinAntimicrobial Agents and Chemotherapy, 1975
- Kinetics and Mechanisms of Degradation of the Antileukemic Agent 5‐Azacytidine in Aqueous SolutionsJournal of Pharmaceutical Sciences, 1975
- BRL.8988 (Talampicillin), a Well-Absorbed Oral Form of AmpicillinAntimicrobial Agents and Chemotherapy, 1974
- PHTHALIDYL D-α-AMINOBENZYLPENICILLINATE HYDROCHLORIDE (PC-183), A NEW ORALLY ACTIVE AMPICILLIN ESTERThe Journal of Antibiotics, 1974
- Relative Stability of Hetacillin and Ampicillin in SolutionJournal of Pharmaceutical Sciences, 1972
- Kinetics and Mechanism of Degradation of Ampicillin in SolutionJournal of Pharmaceutical Sciences, 1969